{"id":"https://openalex.org/W2085095809","doi":"https://doi.org/10.2337/diacare.26.11.2983","title":"Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes","display_name":"Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes","publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W2085095809","doi":"https://doi.org/10.2337/diacare.26.11.2983","mag":"2085095809","pmid":"https://pubmed.ncbi.nlm.nih.gov/14578227"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.26.11.2983","doi":"https://doi.org/10.2337/diacare.26.11.2983","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.26.11.2983","pdf_url":"https://diabetesjournals.org/care/article-pdf/26/11/2983/590873/dc1103002983.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://diabetesjournals.org/care/article-pdf/26/11/2983/590873/dc1103002983.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001188908","display_name":"Thomas E. Delea","orcid":"https://orcid.org/0000-0001-5493-1925","observed_orcids":["https://orcid.org/0000-0001-5493-1925"]},"institutions":[{"id":"https://openalex.org/I4210122455","display_name":"Policy Analysis (United States)","ror":"https://ror.org/02jxrxr40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E. Delea","raw_affiliation_strings":["Policy Analysis, Brookline, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policy Analysis, Brookline, Massachusetts","institution_ids":["https://openalex.org/I4210122455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087472431","display_name":"John Edelsberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122455","display_name":"Policy Analysis (United States)","ror":"https://ror.org/02jxrxr40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John S. Edelsberg","raw_affiliation_strings":["Policy Analysis, Brookline, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policy Analysis, Brookline, Massachusetts","institution_ids":["https://openalex.org/I4210122455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038694515","display_name":"May Hagiwara","orcid":"https://orcid.org/0000-0002-5796-2580","observed_orcids":["https://orcid.org/0000-0002-5796-2580"]},"institutions":[{"id":"https://openalex.org/I4210122455","display_name":"Policy Analysis (United States)","ror":"https://ror.org/02jxrxr40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"May Hagiwara","raw_affiliation_strings":["Policy Analysis, Brookline, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policy Analysis, Brookline, Massachusetts","institution_ids":["https://openalex.org/I4210122455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055762239","display_name":"Gerry Oster","orcid":"https://orcid.org/0000-0002-8637-7495","observed_orcids":["https://orcid.org/0000-0002-8637-7495"]},"institutions":[{"id":"https://openalex.org/I4210122455","display_name":"Policy Analysis (United States)","ror":"https://ror.org/02jxrxr40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerry Oster","raw_affiliation_strings":["Policy Analysis, Brookline, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policy Analysis, Brookline, Massachusetts","institution_ids":["https://openalex.org/I4210122455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061795428","display_name":"Lawrence S. Phillips","orcid":"https://orcid.org/0000-0002-6542-8046","observed_orcids":["https://orcid.org/0000-0002-6542-8046","https://orcid.org/0000-0002-7279-4896"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence S. Phillips","raw_affiliation_strings":["Division of Endocrinology, School of Medicine, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, School of Medicine, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.5459,"has_fulltext":true,"cited_by_count":216,"citation_normalized_percentile":{"value":0.98666182,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"26","issue":"11","first_page":"2983","last_page":"2989"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.032099999487400055,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":1.0},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9660000205039978},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9300000071525574},{"id":"https://openalex.org/keywords/risk-factors-for-heart-failure","display_name":"heart failure risk","score":0.7269999980926514},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6480000019073486},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7609999775886536},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.37700000405311584},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6579999923706055},{"id":"https://openalex.org/keywords/cardiovascular-complications","display_name":"cardiovascular complications","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9442534446716309},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.8718910217285156},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6657434105873108},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.6385742425918579},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6222625374794006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6117063760757446},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5783800482749939},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5275368690490723},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.46555668115615845},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.44387513399124146},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.34562402963638306},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18528318405151367},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1336551010608673},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D007348","descriptor_name":"Insurance, Health","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2337/diacare.26.11.2983","doi":"https://doi.org/10.2337/diacare.26.11.2983","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.26.11.2983","pdf_url":"https://diabetesjournals.org/care/article-pdf/26/11/2983/590873/dc1103002983.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:14578227","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14578227","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.614.8376","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.614.8376","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ops.org.ar/publicaciones/cursos_virtuales/cursovirtualmedicamentos/dia2/bibliografia/seguridad/diabetes care 2003.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/diacare.26.11.2983","doi":"https://doi.org/10.2337/diacare.26.11.2983","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.26.11.2983","pdf_url":"https://diabetesjournals.org/care/article-pdf/26/11/2983/590873/dc1103002983.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2085095809.pdf","grobid_xml":"https://content.openalex.org/works/W2085095809.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W132780861","https://openalex.org/W1489558172","https://openalex.org/W1969304680","https://openalex.org/W1984636592","https://openalex.org/W1985268932","https://openalex.org/W1995713981","https://openalex.org/W2006247039","https://openalex.org/W2014877159","https://openalex.org/W2019007750","https://openalex.org/W2046183081","https://openalex.org/W2052806549","https://openalex.org/W2063713206","https://openalex.org/W2069150029","https://openalex.org/W2069884045","https://openalex.org/W2073238039","https://openalex.org/W2077306519","https://openalex.org/W2079508487","https://openalex.org/W2087507912","https://openalex.org/W2103018859","https://openalex.org/W2129168200","https://openalex.org/W2134063697","https://openalex.org/W2140937253","https://openalex.org/W2150291618","https://openalex.org/W2157563219","https://openalex.org/W2164739027","https://openalex.org/W2165832533","https://openalex.org/W2169005776"],"related_works":["https://openalex.org/W7095813076","https://openalex.org/W2008466987","https://openalex.org/W1979369530","https://openalex.org/W2550193084","https://openalex.org/W2947889562","https://openalex.org/W2417760779","https://openalex.org/W2128621400","https://openalex.org/W2106711721","https://openalex.org/W7101254855","https://openalex.org/W1973245422"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,92,228],"incidence":[4,106,199],"of":[5,81,103,107,122,182,200,219,230,248,269,275],"heart":[6,82,108,123,183,201,231,242,249,270],"failure":[7,83,184,202,250],"in":[8,91,239,251],"individuals":[9],"with":[10,43,60,72,79,119,237,241,258],"type":[11,44],"2":[12,45],"diabetes":[13,46,148],"receiving":[14,253],"thiazolidinediones":[15],"(TZDs)":[16],"versus":[17],"other":[18],"oral":[19,50],"antihyperglycemic":[20,51],"agents.":[21],"RESEARCH":[22],"DESIGN":[23],"AND":[24],"METHODS:":[25],"We":[26],"conducted":[27],"a":[28,33,89,114,120],"retrospective":[29],"cohort":[30],"study":[31,39,222],"using":[32],"health":[34],"insurance":[35],"claims":[36,62],"database.":[37],"The":[38,100,217],"sample":[40],"included":[41],"patients":[42,127,210,240,257,265],"who":[47,85,266],"received":[48,86],"an":[49],"agent":[52],"between":[53],"January":[54],"1995":[55],"and":[56,68,157,170,211,260],"March":[57],"2001.":[58],"Those":[59,78],"any":[61],"for":[63,188,208,213,246,264],"TZDs":[64,225,236],"were":[65,98,131],"designated":[66],"\"exposed,\"":[67],"each":[69],"was":[70,105,111,180,206],"compared":[71],"five":[73],"randomly":[74],"selected":[75],"unexposed":[76],"patients.":[77],"diagnoses":[80],"or":[84,88,116,147,155,162],"digoxin":[87],"diuretic":[90],"year":[93],"before":[94],"their":[95],"index":[96],"date":[97],"excluded.":[99],"primary":[101],"measure":[102],"interest":[104],"failure,":[109,243,271],"which":[110],"defined":[112],"as":[113,273],"hospitalization":[115],"outpatient":[117],"visit":[118],"diagnosis":[121],"failure.":[124,232],"RESULTS:":[125],"TZD":[126,178,209],"(n":[128,136],"=":[129,137,193],"5441)":[130],"younger":[132],"than":[133],"control":[134,214],"subjects":[135],"28103)":[138],"but":[139],"more":[140,168],"likely":[141],"to":[142],"have":[143,158],"coronary":[144],"artery":[145],"disease":[146],"complications,":[149],"receive":[150],"ACE":[151],"inhibitors,":[152],"beta-blockers,":[153],"metformin,":[154],"insulin,":[156],"undergone":[159],"HbA(1c)":[160],"tests":[161],"eye":[163],"exams;":[164],"they":[165],"also":[166],"had":[167],"comorbidities":[169],"higher":[171],"costs":[172],"(all":[173],"P":[174,195],"<":[175,196],"0.05).":[176],"However,":[177],"use":[179,235],"predictive":[181],"even":[185],"after":[186],"controlling":[187],"these":[189,254],"variables":[190],"(hazard":[191],"ratio":[192],"1.7,":[194],"0.001).":[197],"Adjusted":[198],"at":[203],"40":[204],"months":[205],"8.2%":[207],"5.3%":[212],"subjects.":[215],"CONCLUSIONS:":[216],"results":[218],"this":[220],"observational":[221],"suggest":[223],"that":[224],"may":[226],"increase":[227],"risk":[229],"Physicians":[233],"should":[234],"caution":[238],"remain":[244],"vigilant":[245],"manifestations":[247],"those":[252],"drugs":[255],"(especially":[256],"cardiovasculopathy),":[259],"consider":[261],"alternate":[262],"therapies":[263],"develop":[267],"symptoms":[268],"such":[272],"shortness":[274],"breath.":[276]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}